Đang chuẩn bị liên kết để tải về tài liệu:
Tofacitinib for the treatment of inflammatory bowel disease-associated arthritis: Two case reports

Musculoskeletal manifestations are common extraintestinal manifestations of inflammatory bowel disease. Tofacitinib is a Janus kinase inhibitor approved for treating rheumatoid arthritis and ulcerative colitis. There are limited data on the efficacy of tofacitinib in managing inflammatory bowel disease-associated arthritis. |